Investors Careers Therapeutic Areas News Resources About Us Contact Us Coronavirus Business Continuity Coronavirus Business Continuity Resources > Coronavirus Business Continuity As a healthcare company committed to improving the lives of patients around the world, LivaNova is closely monitoring the coronavirus situation and is reacting accordingly as the issues evolve. U.S. Temporary Modification to Product Indications for Use To address coronavirus (COVID-19) and per the U.S. Food and Drug Administration, LivaNova is now permitted to modify cardiopulmonary products indications for use to include ECMO therapy beyond six hours. This applies to the following products: S5® heart-lung machine CP5® centrifugal pump driver Revolution® centrifugal pump Inspire® family of oxygenators EOS® PMP oxygenator LifeSPARC™ pump and controller TandemHeart® pump and controller TandemLung® oxygenator ProtekDuo® cannulae EasyFlow™ Aortic Cannula Remote Access Perfusion (RAP) Femoral Venous Cannula FAQs – Use of LivaNova ECMO/CPB Devices for COVID-19 Patients View the full press release here. VNS Therapy® for Epilepsy We understand the additional challenges that COVID-19 has created for people with epilepsy and especially those with uncontrolled seizures. We encourage you to stay in contact with your healthcare team in order to make the best possible decisions both to optimize epilepsy care for you or your loved one and also to minimize the risks of COVID-19. Learn more LivaNova Coronavirus (COVID-19) Business Continuity Statement We extend our thanks and gratitude to the frontline responders around the globe for their commitment to fighting coronavirus (COVID-19) and their dedication to the many patients who are in need of treatment. Due to the impact of the global coronavirus pandemic, LivaNova has taken the following actions, all while keeping customers, patients and our employees top of mind: • Optimized Manufacturing: LivaNova has optimized its manufacturing for various production lines at its manufacturing locations. Despite some reduction in manufacturing, our facilities continue to fulfill product needs and we are working with suppliers to ensure we have steady flow of materials and products as we are committed to ensuring product availability, customer support and medical education. • Emphasis on Employee Safety: The health and safety of our employees is of the utmost importance. We are protecting production-critical employees at manufacturing sites through measures like additional cleaning measures, social distancing and the use of personal protective equipment. We have also implemented remote working options for many employees to help minimize exposure and reduce the spread of the virus. We thank our employees for their tireless efforts to ensure our business operations continue and for their commitment to providing life-changing products and therapies to patients around the world. • Importance of Giving Back: To support healthcare providers, LivaNova employees from around the globe have banded together to give back. To date, we have donated 23,000 masks and five cardiopulmonary machines to hospitals in need in China. In Mirandola, Italy, our employees donated to local charities to provide masks for a local hospital and our site made a donation to support a volunteer ambulance service. Additionally, in Houston, Texas, we were able to give 2,300 masks to nurses at a local hospital who were running low on supplies. We are so proud of our LivaNova employees who embody our values to put patients first, act with agility and unite to show their collaborative strength. Circumstances are dynamic and our plans adjust based on the latest information. We will provide updates as the situation develops. Should you have any questions, please do not hesitate to contact your local LivaNova representative. Thank you for your understanding and support. Contact Us First Name: Last Name: Email: I am: (select a category) Healthcare Professional Investor Patient Media Other Country: (select a country) Afghanistan Albania Algeria Andorra Angola Antigua & Deps Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belgium Belize Benin Bhutan Bolivia Bosnia Herzegovina Botswana Brazil Brunei Bulgaria Burkina Burkina faso Burundi Cambodia Cameroon Canada Cape Verde Central African Rep Chad Chile China Colombia Comoros Congo Costa rica Croatia Cuba Cyprus Czech republic Denmark Djibouti Dominica Dominican Republic East timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Grenada Guatemala Guinea Guyana Haiti Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Romania Russian Federation Rwanda Saint Vincent & the Grenadines Samoa San marino Sao Tome & Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri lanka St Kitts & Nevis St Lucia Sudan Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Yemen Zambia Zimbabwe State / Province / Other: City: Phone Number: Message: Privacy Policies: I read and agree with LivaNova Privacy Policies *Denotes required field. Therapeutic Areas Advanced Circulatory Support Cardiopulmonary Difficult-to-Treat Depression Drug-Resistant Epilepsy Heart Failure Heart Valves Obstructive Sleep Apnea Resources Contact Us Customer Service Research Support Request Donations & Grants About Us Leadership Ethics & Compliance Modern Slavery Statement Conflict Minerals Terms of Use Privacy Statement Privacy Notice Patents Cookie Policy © 2020 LivaNova PLC LivaNova PLC - Registered in England and Wales - Registered No. 09451374 - 20 Eastbourne Terrace, London, W2 6LG, United Kingdom LivaNova Cookie Consent By clicking “Accept Cookies”, you agree to the storing all cookies on your device to enhance site navigation, analyze site usage, and assist in our efforts to deliver well-tailored marketing services Link to Cookie Policy Cookies Settings Accept Cookies